Side-by-side comparison
RHHVF vs VRTX — Side-by-side comparison
Neither screens cheaper on EV/FCF, VRTX has the higher ROIC, VRTX has grown revenue faster over five years, and Neither has the cleaner balance sheet by net debt / EBITDA.
RHHVF
Roche Holdings AG DIV RT
Price
$425.05
Market cap
$263.8B
Day %
N/A
VRTX
VERTEX PHARMACEUTICALS INC / MA
Price
N/A
Market cap
N/A
Day %
N/A
RHHVF implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
N/A
VRTX implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
14.1%
5Y indexed stock chart
Static Recharts view indexed to 100 from available annual per-share data.
Quality Scorecard
Build-time composite score for RHHVF.
Grade F
0
/ 100
Quality Radar0 – 20 per axis
Quality Scorecard
Build-time composite score for VRTX.
Grade D
38
/ 100
Quality Radar0 – 20 per axis